gemcitabine has been researched along with Livedo Reticularis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Omueti-Ayoade, K; Yang, M; Zemtsov, A; Zemtsov, R | 1 |
1 other study(ies) available for gemcitabine and Livedo Reticularis
| Article | Year |
|---|---|
Livedo reticularis as an initial clinical manifestation of gemcitabine-induced hemolytic uremic syndrome.
Topics: Antineoplastic Agents; Deoxycytidine; Drug Eruptions; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Livedo Reticularis; Middle Aged; Pancreatic Neoplasms | 2012 |